Tata Capityal

Tata Capital to Acquires Stakes in Biocon Biologics for Rs 225 Cr

The transaction is subject to standard condition precedents and approvals. After the completion of the transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics.